<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

	<!-- Basic Page Needs
  ================================================== -->
    <script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Endocrine &amp; Metabolism</title>
	<meta name="description" content="Course Notes for Endocrine &amp; Metabolism">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0"/>
	
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/content.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/print.css">
	<link href="http://maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css" rel="stylesheet">	
	
	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="https://dl.dropboxusercontent.com/u/157117/Class%20References/favicon.png" type="image/png">

	<!-- iOS Icons
	================================================== -->
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone.png" rel="apple-touch-icon"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad.png" rel="apple-touch-icon" sizes="76x76" />
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone-retina.png" rel="apple-touch-icon" sizes="120x120"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad-retina.png" rel="apple-touch-icon" sizes="152x152" />
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/endocrinology/search.html">
	<div><input type="text" value="Search Endocrine &amp; Metabolism" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/endocrinology">Endocrine &amp; Metabolism</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/endocrinology/search.html">
	<div style="float: left;"><input type="text" value="Search Endocrine &amp; Metabolism" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

<div class="course-index">
	<a href="http://www.schulichnotes.com/endocrinology">Endocrine &amp; Metabolism</a>
</div>

        <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">Monday, October 6</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/intro-endocrinology.html">Introduction to Endocrinology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/endocrine-physiology-hormone-receptors-feedback-loops.html">Endocrine Physiology, Hormone Receptors & Feedback Loops</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/thyroid-physiology-pharmacology.html">Thyroid Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/thyroid-pharmacology.html">Thyroid Pharmacology</a></li></ul>
		<li class="day">Tuesday, October 7</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/07/clinical-presentation-evaluation-thyroid-disease.html">Clinical Presentation &amp; Evaluation of Thyroid Disease</a></li></ul>
		<li class="day">Wednesday, October 8</li>
		<ul></ul>
		<li class="day">Thursday, October 9</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/09/thyroid-parathyroid-focal-cases.html">Thyroid/Parathyroid Focal Cases</a></li></ul>
		<li class="day">Friday, October 10</li>
		<ul></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">Tuesday, October 14</li>
		<ul></ul>
		<li class="day">Wednesday, October 15</li>
		<ul></ul>
		<li class="day">Thursday, October 16</li>
		<ul></ul>
		<li class="day">Friday, October 17</li>
		<ul></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">Monday, October 20</li>
		<ul></ul>
		<li class="day">Tuesday, October 21</li>
		<ul></ul>
		<li class="day">Wednesday, October 22</li>
		<ul></ul>
		<li class="day">Thursday, October 23</li>
		<ul></ul>
		<li class="day">Friday, October 24</li>
		<ul></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, October 27</li>
		<ul></ul>
		<li class="day">Tuesday, October 28</li>
		<ul></ul>
		<li class="day">Wednesday, October 29</li>
		<ul></ul>
		<li class="day">Thursday, October 30</li>
		<ul></ul>
		<li class="day">Friday, October 31</li>
		<ul></ul>
	</ul>
	<li class="week">Week 5</li>
	<ul>
		<li class="day">Monday, November 3</li>
		<ul></ul>
		<li class="day">Tuesday, November 4</li>
		<ul></ul>
		<li class="day">Wednesday, November 5</li>
		<ul></ul>
	</ul>
</nav>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Thyroid Pharmacology</h1></div>
                <info datetime="2014-10-06">
                    <span class="author"><a href="https://dl.dropboxusercontent.com/u/157117/notes-reference/jekyll/_site/contributors.html#kevanlu">Kevan Lu</a></span>
                    <span class="date">Monday, October 06, 2014</span>
                </info>
                <div class="body"><h2 id="lecture-objectives"><strong>Lecture Objectives</strong></h2>
<ol>
  <li>List the drugs used in treating hyperthyroid conditions.</li>
  <li>Describe the pharmacology, kinetics and mechanism of action of the thioamides and anionic inhibitors.</li>
  <li>Describe the adverse effects associated with use of the drugs used in treating hyperthyroidism.</li>
  <li>Describe the therapeutic uses of iodide and iodinated contrast media.</li>
  <li>Describe the therapeutic and diagnostic uses of radioactive iodine.</li>
  <li>Describe the adverse effects associated with the use of iodine and iodinated compounds.</li>
</ol>

<h1 id="thyroid-pharmacology">Thyroid Pharmacology</h1>
<hr />

<p><span class="sidenote">You don’t need to know this stereochemistry for the final, but it’s still pretty neat!</span></p>

<ul>
  <li>Recall that there are <em>2 forms of T3</em> → T3, and rT3 (reverse T3).</li>
  <li>One is highly active, and the other is inactive. Why is there a difference?
    <ul>
      <li>You can have 2 different binding arrangements of 3 iodines on the aromatic rings.
        <ul>
          <li>3,5,3’-tri-iodothyronine (T3) is a highly active thyroid hormone.</li>
          <li>3,3’,5’-tri-iodothyronine (rT3) is inactive.</li>
        </ul>
      </li>
      <li>The ether group between the two aromatic rings has a bent shape, meaning that the 2 rings in the thyroid hormone aren’t coplanar; they’re bent.</li>
      <li>Iodine is a big atom, so when the iodine groups are attached proximally to the ether group, they’re so big that they cause the bond to twist.</li>
      <li>This changes the shape of the rT3 hormone so it <em>doesn’t fit the receptor</em>, making it inactive.</li>
    </ul>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/36sdl5n7.png" /></p>

<ul>
  <li>The asterisk marks a location where there can be enantiomerism. 
    <ul>
      <li>So there can be L-thyroxine, and D-thyroxine.</li>
      <li><em>All active thyroid hormones are in a L-configuration.</em></li>
      <li><strong>L-thyroxine</strong> = <em>levothyroxine</em>, which is what’s given to patients with hypothyroidism.</li>
      <li>There is also a D-configuration thyroxine, which is comparatively unimportant (it has lipid lowering properties).</li>
    </ul>
  </li>
</ul>

<h2 id="conversion-of-t4-to-t3"><strong>Conversion of T4 to T3</strong></h2>
<ul>
  <li>Recall that most T3 is produced in peripheral tissue, converted from T4.</li>
  <li>Conversion (activation) occurs by removing the 5’ iodine of the outer ring of T4.</li>
  <li>Although T4 still has a biological effect, it’s so much weaker than that of T3 that it can be considered a prohormone for T3.</li>
  <li>The <em>deiodinases</em> that convert T4 → T3 are <em>stereoselective</em>, and require a <em>selenium</em> prosthetic group.
    <ul>
      <li>In extremely rare instances of selenium deficiency, we can have impaired conversion of T4 → T3.</li>
    </ul>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/t94f8ut-.png" /></p>

<ul>
  <li>The two <em>deiodinases</em> we saw in the last lecture were D2 and D3.</li>
  <li>Recall that D3 not only converts T4 to rT3 (inactive), but also T3 to T2.</li>
  <li>In other words, <em>D3 is an inactivator</em> of thyroid hormone.</li>
</ul>

<blockquote>
  <h4 id="remember"><strong>Remember</strong></h4>
  <ul>
    <li><strong>D2</strong> is a <em>thyroid hormone activator</em> (it converts T4 → T3).</li>
    <li><strong>D3</strong> is a <em>thyroid hormone inactivator</em> (it converts T4 → rT3, and T3 → T2).</li>
  </ul>
</blockquote>

<h1 id="treatment-of-hypothyroidism">Treatment of Hypothyroidism</h1>
<hr />

<ul>
  <li><strong>Causes of Hypothyroidism</strong>:
    <ul>
      <li><em>Hashimoto’s Thyroiditis</em> → most common cause, especially in women. Autoimmune destruction of the thyroid gland.</li>
      <li>Impaired hormone synthesis.</li>
      <li>Destruction of thyroid tissue (eg. irradiation, surgery).</li>
      <li>Secondary to pituitary/hypothalmic problems (eg. TSH deficit).</li>
      <li>Congenital (cretinism).</li>
      <li>Pharmacological (eg. following consumption of antithyroid drugs/foods).</li>
    </ul>
  </li>
  <li>Pharmacological treatment of hypothyroidism is by <em>replacement therapy</em>.
    <ul>
      <li>Replacement therapy is so effective that we actually use it to treat hyperthyroidism now, by removing the thyroid gland, and then using replacement hormone.</li>
    </ul>
  </li>
  <li>Hormone preparations are either <em>animal source extracts</em> or <em>synthetic hormone</em>.
    <ul>
      <li>The latter is by far a better choice, because animal extracts are less pure, and may have antigens that trigger an immune reaction.</li>
      <li><strong>Synthetic T4</strong> is available as <em>levothyroxine</em>, aka. <em>Synthroid©</em>.</li>
      <li><strong>Synthetic T3</strong> is available as <em>liothyronine</em>, aka. <em>Cytomel©</em>.</li>
    </ul>
  </li>
  <li>An example of an animal source extract is <em>thyroid dessicated USP</em>.
    <ul>
      <li>USP = United States Pharmacopeia. A <em>pharmacopeia</em> is a drug listing, which includes standards and records of old drugs</li>
      <li>There’s a site online called ‘<a href="http://www.stopthethyroidmadness.com/">Stop the Thyroid Madness</a>’ that is full of (wrong) material about how synthetic hormone causes horrible side effects.</li>
      <li>They advocate the use of animal extract, which ironically is even more likely to have material in it that will lead to an allergic response.</li>
    </ul>
  </li>
  <li><strong>Synthetic T4 is the hormone of choice</strong> because T4 has a more consistent potency, and a longer duration of action.</li>
  <li><em>T3 is used only occassionally, when a faster onset of action is required</em> (eg. with a myxedema coma):
    <ul>
      <li><strong>Myxedema coma</strong> → a loss of brain function as a result of severe, longstanding hypothyroidism.</li>
    </ul>
  </li>
  <li><em>Synthetic hormones have few side effects</em>, aside from those that are a consequence of their biological function (eg. increased heart rate, increased metabolism, tremors, etc). These are known as <em>extension effects</em>.
    <ul>
      <li>These symptoms may often mimic <em>sympathetic hyperactivity</em>.</li>
    </ul>
  </li>
  <li>The usual tablet dosage in an adult is 100 µg/D (in kids, it’s 100 µg/m<sup>2</sup>/d, so it’s corrected by body area).
    <ul>
      <li>When starting hormone replacement therapy, it’s best to slowly ramp up the dosage to a therapeutic level, to let the patient’s body acclimatize. </li>
    </ul>
  </li>
</ul>

<h1 id="treatment-of-hyperthyroidism">Treatment of Hyperthyroidism</h1>
<hr />

<ul>
  <li>There are 3 possible treatment routes for hyperthyroidism:
    <ol>
      <li><strong>Medication</strong> → drugs which diminish the synthesis and/or release of active thyroid hormone.</li>
      <li><strong>Radioactive Iodine Ablation</strong> → ablation of hyperactive thyroid cells using radioactive iodine.</li>
      <li><strong>Surgery</strong> → removal of the thyroid gland and thyroid hormone replacement.</li>
    </ol>
  </li>
</ul>

<hr />

<h2 id="medication"><strong>Medication</strong></h2>

<ul>
  <li>Medications for hyperthyroidism aim to <em>reduce synthesis</em> or <em>reduce release</em> of thyroid hormone.</li>
  <li>These include:
    <ol>
      <li><strong>Thioamides</strong> → <em>Methimazole</em>, and <em>Propylthiouracil</em>.</li>
      <li><strong>Iodine</strong> → ironically, <em>excess iodine anion</em> can actually diminish thyroid function.
        <ul>
          <li>This is known as the <strong>Wolff–Chaikoff effect</strong> → a reduction in thyroid hormone levels caused by ingestion of a large amount of iodine.</li>
        </ul>
      </li>
    </ol>
  </li>
</ul>

<p><span class="sidenote"><b>Objectives</b>: (1) List the drugs used in treating hyperthyroid conditions. (2) Describe the pharmacology, kinetics and mechanism of action of the thioamides and anionic inhibitors.</span></p>

<h3 id="thioamides"><strong>Thioamides</strong></h3>
<ul>
  <li><em>Thioamides</em> are used in several hyperthyroid conditions, including Graves’ disease, thyrotoxicosis, and toxic nodular goitres.</li>
  <li>Examples include <strong>methimazole</strong> and <strong>propylthiouracil</strong>.</li>
  <li><strong>Mechanism of action</strong>:
    <ul>
      <li><em>Inhibits the incorporation of iodine</em> into the tyrosine residues on thyroglobulin.</li>
      <li><em>Inhibits the coupling of MIT and DIT</em>, which is needed to cleave T3/T4 from thyroglobulin.</li>
    </ul>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/2bpbcnss.png" /></p>

<blockquote>
  <h4 id="remember-1"><strong>Remember</strong></h4>
  <ul>
    <li><em>Thioamides</em> have 2 mechanisms of action:
      <ul>
        <li>They <em>inhibit the incorporation of iodine</em> onto thyroglobulin.</li>
        <li>They <em>inhibit the coupling of MIT and DIT</em>, which is needed to cleave T3/T4 from thyroglobulin.</li>
      </ul>
    </li>
  </ul>
</blockquote>

<ul>
  <li>As a result, there is reduced hormone synthesis.</li>
  <li><em>Treatment takes a while</em>, because pre-existing stores of thyroid hormone must be depleted.</li>
  <li><em>Thioamides used in Canada include:</em>
    <ol>
      <li><strong>Methimazole</strong> (MMI)
        <ul>
          <li>Is much stronger than propylthiouracil.</li>
        </ul>
      </li>
      <li><strong>Propylthiouracil</strong> (PTU)
        <ul>
          <li>Less potent, however it does have a diminished ability to cross the placenta versus MMI.</li>
          <li>As a result, <em>propylthiouracil is used during the first trimester of pregnancy</em>, because of fears of potential teratogenic effects.
            <ul>
              <li>PTU has a small risk of <strong>fulminant hepatitis</strong>, so this is basically the only time when it’s used.</li>
            </ul>
          </li>
          <li>Additionally, <em>PTU has a faster onset of action</em>.
            <ul>
              <li>This is because PTU has another function: it inhibits the D2 deiodinase which converts T4 to T3.</li>
              <li>So it has a second effect of inhibiting T4 → T3 conversion.</li>
            </ul>
          </li>
        </ul>
      </li>
    </ol>
  </li>
  <li>Minor side-effects of thioamides include fever, and rashes. Rarer problems include cholestatic jaundice, hepatitis, and arthralgia.</li>
  <li>All thioamides carry the small risk of causing <strong>agranulocytosis</strong> (0.3-0.6% of patients).</li>
</ul>

<p><span class="sidenote"><b>Objective:</b> Describe the adverse effects associated with use of the drugs used in treating hyperthyroidism.</span></p>

<blockquote>
  <h4 id="comparison-of-thioamides"><strong>Comparison of Thioamides</strong></h4>

  <table>
    <thead>
      <tr>
        <th style="text-align: left"> </th>
        <th style="text-align: left"><em>Methimazole</em></th>
        <th style="text-align: left"><em>Propylthiouracil</em></th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left">Strength</td>
        <td style="text-align: left"><em>Strong</em></td>
        <td style="text-align: left"><em>Weak</em> (~10x less effective than MMI)</td>
      </tr>
      <tr>
        <td style="text-align: left">Used in</td>
        <td style="text-align: left"><em>First-line</em></td>
        <td style="text-align: left"><em>Only in 1st trimester of pregnancy</em></td>
      </tr>
      <tr>
        <td style="text-align: left">Onset of Action</td>
        <td style="text-align: left"><em>Slower</em></td>
        <td style="text-align: left"><em>Faster</em></td>
      </tr>
      <tr>
        <td style="text-align: left">Serious (rare) Adverse Effects</td>
        <td style="text-align: left"><em>Agranulocytosis</em></td>
        <td style="text-align: left"><em>Agranulocytosis</em> and <em>Fulminant hepatitis</em></td>
      </tr>
    </tbody>
  </table>
</blockquote>

<p><span class="sidenote"><b>Objective</b>: Describe the therapeutic uses of iodide and iodinated contrast media.</span></p>

<h3 id="iodide"><strong>Iodide</strong></h3>
<ul>
  <li>Counterintuitively, iodide (I<sup>-</sup>) itself has an antithyroid activity.</li>
  <li>At pharmacological doses (ie. high doses), iodide inhibits organification reactions, and the release of hormones from the thyroid.
    <ul>
      <li><em>Organification</em> = attaching elemental iodide to an organic moiety (eg. thyroglobulin).</li>
    </ul>
  </li>
  <li>In other words, <em>if you have too much iodide, it can depress thyroid function</em>.</li>
  <li>Hence, the response to iodide can be variable → <em>either hypo- or hyper-thyroidism can result</em>.</li>
  <li>iodide is often given as an adjunct to thioamides:
    <ul>
      <li>In this case, the thioamide must be given first. If you give the iodide first, it may result in an initial increase in thyroid hormone formation, which would exacerbate hyperthyroidism.</li>
      <li>If iodide is used in treatment, <em>you cannot use radioactive iodide</em> therapy for several weeks. This is because it won’t be taken up by the thyroid with such a high pre-existing supply.</li>
    </ul>
  </li>
  <li><strong>Prolonged iodide use is not suggested</strong>:
    <ul>
      <li>Using iodide for greater than 6-8 weeks introduces the risk of the thyroid ‘escaping’ from its inhibitory effects.</li>
      <li>This can lead to <em>severe thyrotoxicosis</em> (the thyroid is now producing as much thyroid hormone as it wants), which can be life threatening.</li>
    </ul>
  </li>
  <li><strong>Adverse Effects</strong>:
    <ul>
      <li>Collectively known as “iodism”, and may include fever, rash, mucous membrane ulcers, and, rarely, anaphylactoid reactions. Toxicity is uncommon.</li>
    </ul>
  </li>
  <li><strong>iodide in Medications</strong>:
    <ul>
      <li>Some medications have <i>substantial</i> iodide content.</li>
      <li>Antiseptics often contain iodide.</li>
      <li><strong>Amiodarone</strong> (which we saw in the <a href="http://www.schulichnotes.com/cardiology/2014/02/12/antiarrythmics.html">Antiarrythmics</a> lecture in Cardiology) has a <i>huge</i> amount of iodide (75 mg/tablet)!</li>
      <li><em>Radio-contrast media</em> also has a high iodide content.
        <ul>
          <li>In fact, sometimes, contrast is used as an ‘unlabeled’ treatment for patients in a thyroid storm, since it’s a readily accessible source of iodide.</li>
        </ul>
      </li>
    </ul>
  </li>
</ul>

<hr />

<h2 id="radioactive-iodine"><strong>Radioactive Iodine</strong></h2>

<p>RADIOACTIVE IODINE
Only 131I is used in the treatment of hyperthyroidism. It has a half-life of 8 days: &gt;99% is expended within 56 days. Radiation consists of  rays and  particles.
This is a generally safe approach
The other isotope, 123I, is a -emitter with a half-life of only 13 hours. This permits a relatively brief exposure to radiation during thyroid scans.</p>

<p>Adverse effects of 131I treatment
Usually a very safe and effective mode of therapy. Chief concern is the high incidence of delayed hypothyroidism. Even with an I2 uptake and gland size estimate, some patients will be overtreated. Titration to hypothyroidism and subsequent replacement is an acceptable approach.
There appears to be a rising prevalence of this complication with the passage of time. The longer the interval after treatment, the higher the incidence.
Thyroiditis is also a concern – (use glucocorticoids)</p>

<p>From this point on we will NOT be dealing with drugs currently used in hyperthyroidism
We WILL be dealing with some relevant Toxicology There are toxicological concerns associated with the
antithyroidal effects of several ions.
Some ions are used in industrial processes and exposure of industrial workers may be a problem.</p>

<h2 id="thyroid-toxicology">Thyroid Toxicology</h2>
                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                        <a class="newer" href="http://www.schulichnotes.com/endocrinology/2014/10/06/thyroid-physiology-pharmacology.html"><i class="fa fa-angle-left"></i> Thyroid Physiology</a> 
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/endocrinology/2014/10/07/clinical-presentation-evaluation-thyroid-disease.html">Clinical Presentation &amp; Evaluation of Thyroid Disease <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/endocrinology/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/search.css">	
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>